Joe N. Kornegay

Eccentric contraction injury in dystrophic canine muscle.

Canine X-linked muscular dystrophy in Japan (CXMDJ).

Polymerase chain reaction (PCR) amplification of parvoviral DNA from the brains of dogs and cats with cerebellar hypoplasia.

The cranial sartorius muscle undergoes true hypertrophy in dogs with golden retriever muscular dystrophy.

Hematopoietic stem cell transplantation does not restore dystrophin expression in Duchenne muscular dystrophy dogs.

Effects of prednisone in canine muscular dystrophy.

Skinned single fibers from normal and dystrophin-deficient dogs incur comparable stretch-induced force deficits.

Use of a rivet-like titanium clamp closure system to replace an external frontal bone flap after transfrontal craniotomy in a dog.

Radiographic features of Golden Retriever muscular dystrophy.

Cytoplasmic gamma-actin expression in diverse animal models of muscular dystrophy.

A single intravenous injection of adeno-associated virus serotype-9 leads to whole body skeletal muscle transduction in dogs.

Kinematics of gait in golden retriever muscular dystrophy.

Expression of dog microdystrophin in mouse and dog muscles by gene therapy.

Chronic administration of membrane sealant prevents severe cardiac injury and ventricular dilatation in dystrophic dogs.

Widespread muscle expression of an AAV9 human mini-dystrophin vector after intravenous injection in neonatal dystrophin-deficient dogs.

Eccentric contractions induce rapid isometric torque drop in dystrophin-deficient dogs.

An intronic LINE-1 element insertion in the dystrophin gene aborts dystrophin expression and results in Duchenne-like muscular dystrophy in the corgi breed.

Golden retriever muscular dystrophy (GRMD): Developing and maintaining a colony and physiological functional measurements.

Clinical progression of X-linked muscular dystrophy in two German Shorthaired Pointers.

Peptide-based inhibition of NF-κB rescues diaphragm muscle contractile dysfunction in a murine model of Duchenne muscular dystrophy.

Long-term systemic myostatin inhibition via liver-targeted gene transfer in golden retriever muscular dystrophy.

Regulation of the calpain and ubiquitin-proteasome systems in a canine model of muscular dystrophy.

Long-term Restoration of Cardiac Dystrophin Expression in Golden Retriever Muscular Dystrophy Following rAAV6-mediated Exon Skipping.

Polystyrene-coated micropallets for culture and separation of primary muscle cells.

Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies.

The paradox of muscle hypertrophy in muscular dystrophy.

Chronic administration of a leupeptin-derived calpain inhibitor fails to ameliorate severe muscle pathology in a canine model of duchenne muscular dystrophy.